Stock Price Quote

RAYMED LABS LTD.

NSE : NABSE : 531207ISIN CODE : INE741C01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE2.620 (0 %)
PREV CLOSE ( ) 2.62
OPEN PRICE ( ) 2.62
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1
TODAY'S LOW / HIGH ( )2.62 2.62
52 WK LOW / HIGH ( ) 2.082.62
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
- Chairman - Managing Director
Registered Office

Address C-273,Sector-63,Noida,
Gautam Budh Nagar,
Uttar Pradesh-201301

Phone 0120-2426900 / 9412700300

Email raymedlabsltd@gmail.com

Website www.raymedlab.com

Registrars Details
Beetal Financial & Computer Services (P) Ltd
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi
Listing : BSE

NEWS

12Sep Draft Letter of Offer
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submit..
05Sep Public Announcement - Open Offer
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submit..
23Aug Raymed Labs informs about newspaper ad
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Req..
25May Raymed Labs informs about newspaper ad
Pursuant to the Regulation 47 of SEBI (Listing Obligation and Disclosure..
25May Raymed Labs informs about newspaper a
Pursuant to the Regulation 47 of SEBI (Listing Obligation and Disclosure..

Financials

in Millions
QTR Jun 24 ANNUAL 24
Net Profit-0.18-1.02
Gross Profit -0.18 -1.02
Operating Profit -0.16-0.97
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  5987.25 (7.94%)
M.Cap ( in Cr)158942.68
Hester Biosciences (BSE)
peergroup  2379.75 (5.25%)
M.Cap ( in Cr)2024.42
Sanofi India (BSE)
peergroup  6895.70 (1.63%)
M.Cap ( in Cr)15881.23
Glaxosmithkline Phar (BSE)
peergroup  2811.75 (3.79%)
M.Cap ( in Cr)47632.74
Astrazeneca Pharma I (BSE)
peergroup  7864.35 (1.28%)
M.Cap ( in Cr)19660.88

Shareholding Pattern

NON-INSTITUTION 70.68%
PROMOTERS 28.36%
FI/BANKS/INSURANCE 0.96%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Raymed Labs Ltd.

Raymed Labs Ltd. was incorporated in the year 1992. Its today's share price is 2.62. Its current market capitalisation stands at Rs 1.12 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Nisha Goyal, Shreya Dave, Poonam Sharma, Harsh Prabhakar, Ajai Goyal.

It is listed on the BSE with a BSE Code of 531207 , NSE with an NSE Symbol of and ISIN of INE741C01017. It's Registered office is at C-273,Sector-63,NoidaGautam Budh Nagar-201301, Uttar Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are A Kay Mehra & Co, Deepak Gupta

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.